In its third quarter, Teva booked revenue of $4.48 billion. That was 3% higher year over year, and much of that growth came ...

Richard Francis, Teva Pharmaceuticals CEO, joins CNBC's 'Money Movers' to discuss the company's most recent quarter, what's ...

Teva Pharmaceutical Industries is able to absorb any potential tariffs imposed by the Trump administration, the company said ...

Teva Pharmaceuticals USA, based in Parsippany, New Jersey, issued a voluntary recall on Oct. 7 for some of the prazosin ...

Even with Inflation Reduction Act (IRA)-related pressure looming for its top product, Teva Pharmaceuticals is continuing to ...

Revenues grew by 3.4 percent to $4.48 billion from $4.33 billion year-on-year, on the back of strong growth across its brands ...

Teva Pharmaceutical Industries Limited (($TEVA)) has held its Q3 earnings call. Read on for the main highlights of the call. Teva Pharmaceutical ...

Israel-based Phoenix Financial acquired more than 3.5 million additional shares of Teva Pharmaceuticals for an estimated $62.1 million in the third quarter. Post-transaction, the fund reported holding ...

Teva Pharmaceuticals has a new game plan for raising awareness of tardive dyskinesia (TD). | Teva Pharmaceuticals has a new ...

Teva Pharmaceutical (TEVA) stock surges as the company posts better than expected Q3 2025 results and raises the midpoint of ...

Teva Pharmaceuticals USA, issued a voluntary recall on Oct. 7 for approximately 580,000 bottles of blood pressure medication ...

The Food and Drug Administration (FDA) just announced that over 580,000 bottles of blood pressure medications made by Teva ...